Valuation: Sugentech Inc.

Market Cap 60.55B 45.29M 41.05M 37.96M 34.25M 64.55M 4.27B 66.83M 456M 181M 2.28B 170M 166M 7.24B P/E 2024
-5.35x
P/E 2025 -4.03x
Enterprise Value 30.34B 22.7M 20.57M 19.03M 17.17M 32.35M 2.14B 33.49M 229M 90.63M 1.14B 85.19M 83.38M 3.63B EV / Sales 2024
3.27x
EV / Sales 2025 6.76x
Free-Float
76.25%
Yield 2024 *
-
Yield 2025 -
1 day+1.54%
1 week+3.80%
Current month-2.46%
1 month-9.69%
3 months-5.15%
6 months-43.02%
Current year-35.50%
1 week 3,700
Extreme 3700
3,970
1 month 3,700
Extreme 3700
4,580
Current year 3,530
Extreme 3530
8,170
1 year 3,530
Extreme 3530
8,230
3 years 3,530
Extreme 3530
11,500
5 years 3,530
Extreme 3530
23,750
10 years 3,530
Extreme 3530
65,800
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 25/09/2017
Chief Executive Officer 61 25/09/2017
Director of Finance/CFO 56 30/03/2022
Director TitleAgeSince
Director/Board Member 61 25/09/2017
Director/Board Member 59 25/09/2017
Director/Board Member 51 30/03/2022
Date Insider Type Main position Quantity % Market Cap. Importance
02/04/24 Others 18,730 0.1120%
Change 5-day change 1-year change 3-year change Capi.($)
+1.54%+3.80%-48.57%-34.33% 45.29M
+1.18%-1.28%-16.90%+11.78% 188B
+1.85%+1.04%+7.29%+41.70% 126B
-0.88%-4.98%-14.52%+9.40% 118B
+1.36%-5.91%-42.82%+1.32% 92.48B
+2.96%+7.64%-0.80%+84.71% 68.51B
+1.08%+2.90%+12.95%-6.56% 59.39B
+0.89%+4.17%+2.07%+55.03% 55.48B
-0.68%+6.83%-1.08%+55.36% 49.62B
+1.79%+0.10%-0.55%-8.36% 35.17B
Average +1.11%+0.75%-10.29%+21.01% 79B
Weighted average by Cap. +1.04%-0.38%-9.06%+24.75%

Financials

2024 2025
Net sales 10.1B 7.55M 6.84M 6.33M 5.71M 10.76M 712M 11.14M 76.05M 30.16M 380M 28.35M 27.74M 1.21B 9.42B 7.04M 6.38M 5.9M 5.33M 10.04M 664M 10.39M 70.93M 28.13M 355M 26.44M 25.88M 1.13B
Net income -15.19B -11.37M -10.3M -9.53M -8.59M -16.2M -1.07B -16.77M -114M -45.38M -572M -42.65M -41.75M -1.82B -23.31B -17.44M -15.8M -14.62M -13.19M -24.86M -1.64B -25.73M -176M -69.63M -878M -65.45M -64.06M -2.79B
Net Debt -48.51B -36.29M -32.88M -30.41M -27.44M -51.71M -3.42B -53.54M -365M -145M -1.83B -136M -133M -5.8B -30.2B -22.59M -20.47M -18.94M -17.09M -32.2M -2.13B -33.33M -227M -90.2M -1.14B -84.79M -82.99M -3.61B
Projected Income Statement - Annual - Sugentech Inc.
Logo Sugentech Inc.
Sugentech Incorporate is a Korea-based company mainly engaged in the production and sale of in-vitro diagnostic test reagents. The Company is involved in the manufacturing and sale of in vitro diagnostic test reagents, point-of-care testing (POCT) products, folic acid products under the name of SOLGAR, as well as molecular diagnostic reagents. The in vitro diagnostic test reagents are for personal use and are sold under the name SUREARLY. The POCT products are for professional use and are sold under the name INCLIX. In addition, the Company is engaged in therapeutic drug monitoring, as well as drug analysis method development. The Company distributes its products within the domestic market and to overseas markets, including Indonesia.
Employees
148
Date Price Change Volume
13/11/26 ₩3,960.00 +1.54% 100,716
12/11/26 ₩3,900.00 -0.64% 46,521
11/11/26 ₩3,925.00 +0.90% 32,155
10/11/26 ₩3,890.00 0.00% 49,018
09/11/26 ₩3,890.00 +1.97% 43,790
  1. Stock Market
  2. Stocks
  3. A253840 Stock